HLF (gene)
From Wikipedia, the free encyclopedia
|
Hepatic leukemia factor
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | HLF; MGC33822 | |||||||||||||
| External IDs | OMIM: 142385 MGI: 96108 HomoloGene: 31074 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 3131 | 217082 | ||||||||||||
| Ensembl | ENSG00000108924 | ENSMUSG00000003949 | ||||||||||||
| Uniprot | Q16534 | Q5SR29 | ||||||||||||
| Refseq | NM_002126 (mRNA) NP_002117 (protein) |
NM_172563 (mRNA) NP_766151 (protein) |
||||||||||||
| Location | Chr 17: 50.7 - 50.76 Mb | Chr 11: 90.15 - 90.21 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Hepatic leukemia factor, also known as HLF, is a human gene.[1]
This gene encodes a member of the proline and acidic-rich (PAR) protein family, a subset of the bZIP transcription factors. The encoded protein forms homodimers or heterodimers with other PAR family members and binds sequence-specific promoter elements to activate transcription. Chromosomal translocations fusing portions of this gene with the E2A gene cause a subset of childhood B-lineage acute lymphoid leukemias. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.[1]
[edit] References
[edit] Further reading
- LeBrun DP (2004). "E2A basic helix-loop-helix transcription factors in human leukemia.". Front. Biosci. 8: s206-22. PMID 12700034.
- Inaba T, Roberts WM, Shapiro LH, et al. (1992). "Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.". Science 257 (5069): 531-4. PMID 1386162.
- Hunger SP, Ohyashiki K, Toyama K, Cleary ML (1992). "Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.". Genes Dev. 6 (9): 1608-20. PMID 1516826.
- Falvey E, Fleury-Olela F, Schibler U (1995). "The rat hepatic leukemia factor (HLF) gene encodes two transcriptional activators with distinct circadian rhythms, tissue distributions and target preferences.". EMBO J. 14 (17): 4307-17. PMID 7556072.
- Hunger SP, Brown R, Cleary ML (1994). "DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.". Mol. Cell. Biol. 14 (9): 5986-96. PMID 8065331.
- Inaba T, Shapiro LH, Funabiki T, et al. (1994). "DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.". Mol. Cell. Biol. 14 (5): 3403-13. PMID 8164688.
- Hunger SP (1996). "Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis.". Blood 87 (4): 1211-24. PMID 8608207.
- Andersson B, Wentland MA, Ricafrente JY, et al. (1996). "A "double adaptor" method for improved shotgun library construction.". Anal. Biochem. 236 (1): 107-13. doi:. PMID 8619474.
- Hunger SP, Li S, Fall MZ, et al. (1996). "The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.". Blood 87 (11): 4607-17. PMID 8639829.
- Hillier LD, Lennon G, Becker M, et al. (1997). "Generation and analysis of 280,000 human expressed sequence tags.". Genome Res. 6 (9): 807-28. PMID 8889549.
- Yu W, Andersson B, Worley KC, et al. (1997). "Large-scale concatenation cDNA sequencing.". Genome Res. 7 (4): 353-8. PMID 9110174.
- Takahata S, Sogawa K, Kobayashi A, et al. (1998). "Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and clock.". Biochem. Biophys. Res. Commun. 248 (3): 789-94. doi:. PMID 9704006.
- Inukai T, Inaba T, Ikushima S, Look AT (1998). "The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.". Mol. Cell. Biol. 18 (10): 6035-43. PMID 9742120.
- Begbie M, Mueller C, Lillicrap D (1999). "Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes.". DNA Cell Biol. 18 (2): 165-73. doi:. PMID 10073576.
- Ema M, Hirota K, Mimura J, et al. (1999). "Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300.". EMBO J. 18 (7): 1905-14. doi:. PMID 10202154.
- Honda H, Inaba T, Suzuki T, et al. (1999). "Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia.". Blood 93 (9): 2780-90. PMID 10216071.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Matsunaga T, Inaba T, Matsui H, et al. (2004). "Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.". Blood 103 (8): 3185-91. doi:. PMID 15070701.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:. PMID 15489334.
[edit] External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

